Pharmaceutical company developing and manufacturing generic, brand and biosimilar products
| Year | Firm | Period | Expenses | Doc |
|---|---|---|---|---|
| 2026 | EAST END GROUP, LLC |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
— |
| Firm | Filings | Expenses |
|---|---|---|
| EAST END GROUP, LLC | 35 | — |
| Issue | Activities |
|---|---|
| Health Issues | 35 |
| Manufacturing | 3 |
| Tariff (miscellaneous tariff bills) | 3 |